COVID-19

Coronavirus

COVID-19

The evidence base on COVID-19 seeks to provide clinicians, program managers, and community members with credible up-to-date information on the relationship between viral hepatitis and liver disease with COVID-19. 

Synthesis on COVID-19 and liver disease

Researchers and experts from across the world have been working rapidly to understand theinteraction of co-morbidities and COVID-19, including liver disease. In this synthesis published in April of 2020, Dr. Ward summarized the current status of the evidence on COVID-19 and liver disease.

Clinical Liver Disease series

The Coalition worked with Clinical Liver Disease, a journal of AASLD, to publish an 8 article series related to COVID-19 and liver disease.

Dr. Ward, Director of the Coalition, co-authored two of these articles:

Read the full series here.

Other resources

AASLD EXPERT PANEL CONSENSUS STATEMENT: VACCINES TO PREVENT COVID-19 INFECTION IN PATIENTS WITH LIVER DISEASE

ANALYZING AND USING ROUTINE DATA TO MONITOR THE EFFECTS OF COVID-19 ON ESSENTIAL HEALTH SERVICES: PRACTICAL GUIDE FOR NATIONAL AND SUBNATIONAL DECISION-MAKERS

CLINICAL BEST PRACTICE ADVICE FOR HEPATOLOGY AND LIVER TRANSPLANT PROVIDERS DURING THE COVID-19 PANDEMIC: AASLD EXPERT PANEL CONSENSUS STATEMENT

EASL POSITION PAPER ON THE USE OF COVID-19 VACCINES IN PATIENTS WITH CHRONIC LIVER DISEASES, HEPATOBILIARY CANCER AND LIVER TRANSPLANT RECIPIENTS

OUTCOMES FOLLOWING SARS-CoV-2 INFECTION IN PATIENTS WITH CHRONIC LIVER DISEASE: AN INTERNATIONAL REGISTRY STUDY

WGO GUIDANCE FOR THE CARE OF PATIENTS WITH COVID-19 and LIVER DISEASE 

Relevant links EASL: https://easl.eu/covid-19-and-the-liver/

AASLD: https://www.aasld.org/about-aasld/covid-19-and-liver

Last day updated 20 Nov 2023